Efficacy and Safety of Upadacitinib in a Case of Pediatric Acute Severe Ulcerative Colitis and Immune Thrombocytopenia

Affiliations

¹ Department of Translational Medical Science, Section of Pediatrics, University of Naples "Federico II," Naples, Italy.
² Oncohematology Unit, Department of Oncology, Hematology and Cellular Therapies, Santobono-Pausilipon Children Hospital, Naples, Italy.
³ Department of Woman, Child and General and Specialistic Surgery, University of Campania "L. Vanvitelli," Naples, Italy.

Benedetta Bocchini et al. Inflamm Bowel Dis. 2025.

. 2025 Jul 1:izaf139.

doi: 10.1093/ibd/izaf139. Online ahead of print.

¹ Department of Translational Medical Science, Section of Pediatrics, University of Naples "Federico II," Naples, Italy.
² Oncohematology Unit, Department of Oncology, Hematology and Cellular Therapies, Santobono-Pausilipon Children Hospital, Naples, Italy.
³ Department of Woman, Child and General and Specialistic Surgery, University of Campania "L. Vanvitelli," Naples, Italy.

Erratum in

Correction to: Efficacy and Safety of Upadacitinib in a Case of Pediatric Acute Severe Ulcerative Colitis and Immune Thrombocytopenia.
[No authors listed] [No authors listed] Inflamm Bowel Dis. 2025 Dec 1;31(12):3494. doi: 10.1093/ibd/izaf245. Inflamm Bowel Dis. 2025. PMID: 41176806 Free PMC article. No abstract available.

No abstract available

Keywords: immune thrombocytopenia; pediatric inflammatory bowel disease; ulcerative colitis; upadacitinib.